MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
OrthAlign is a handheld navigation device that allows for accurate component positioning for total and partial knee and total hip arthroplasty.
Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting
The next-generation Evolut FX system is refined with key enhancements including gold markers built into the frame to facilitate visualization of implant depth and valve commissure location during TAVR procedures
Medtronic Launches World’s First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set.
IRRAS has signed a commercial agreement with Medtronic, starting with a pilot phase where Medtronic will have the exclusive right to promote the IRRAflow system in certain sales territories in the United States.
Centinel Spine Announces First Commercial Use of prodisc® C SK Cervical Total Disc Replacement Product
Along with the currently available prodisc implant, Centinel Spine has the broadest offering of cervical TDR solutions in the world to address individual patient anatomy and meet surgeon preference needs.
Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery
“We see the positive impact that the Intracept Procedure has on patients, and expanded society support of Basivertebral Nerve Ablation further underscores the efficacy of this treatment for chronic vertebrogenic low back pain,” said Tyler Binney, President and CEO of Relievant Medsystems. “These updated guidelines, in addition to our substantial base of clinical evidence, will help to continue driving awareness and adoption of this proven therapy.”